Glyco-Immune Diagnostic Signatures and Therapeutic Targets of Mesothelioma
Abstract
The focus of this grant was to investigate immunoprofiles for serum antibodies to aberrant glycans in human and animal models of mesothelioma. This was accomplished using a one of a kind printed glycan array which is at NYU School of Medicine (NYUSoM). It was hoped that these experiments will allow us to diagnose and prognosticate mesothelioma more accurately in the future. We were severely limited by our ability to start the human mesothelioma glycoprofiles as well as the animal profiles due to delivery and set up times for our one of a kind glycomics laboratory at NYUSoM. We summarize our findings in the final report.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2015
- Accession Number
- ADA637021
Entities
People
- Harvey I Pass
- Margaret Huflejt
Organizations
- New York University